ロード中...
Hypocalcaemia in patients with prostate cancer treated with a bisphosphonate or denosumab: prevention supports treatment completion
BACKGROUND: Most patients with advanced prostate cancer develop bone metastases, which often result in painful and debilitating skeletal-related events. Inhibitors of bone resorption, such as bisphosphonates and denosumab, can each reduce the incidence of skeletal-related events and delay the progre...
保存先:
| 出版年: | BMC Urol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6148993/ https://ncbi.nlm.nih.gov/pubmed/30236112 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12894-018-0393-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|